Group Company Lindab is an international Group that develops, manufactures, markets and distributes products and system solutions for simplified construction and improved indoor climate. The products are characterized by high quality, ease of assembly, energy efficiency, consideration towards the environment, and are delivered with high levels of service.
Project in Yaroslavl: LLC Lindab Buildings
Construction and operation of construction elements production plant (overall capital investment 961,7 million roubles). Complete industrial and commercial buildings production plant with use of metal constructions began its work in 2009; it is the first Lindab Company plant in Russia. Steel building package consists of basic bearing structure, system of wall and roof beams, wall and roof systems, accessories and energy saving insulation. Launch of the plant substantially increased general manufacturing facilities of the company and cut costs of building packages for the Russian consumers, preserving at the same time the high quality of Lindab production.
Takeda Pharmaceutical Company Limited (Takeda) Pharmaceutical Company Limited (Takeda) is a research-based global company with its main focus on pharmaceuticals. Takeda has an active commercial presence in the therapeutic areas of metabolic diseases, cardiovascular health, gastroenterology, oncology and vaccine production. The company owns diversified portfolio, which includes medications for general and specialized therapy, branded generics and non-prescription medications.
Project in Yaroslavl: Takeda Pharmaceutical Company Limited
Construction of the plant for manufacturing of sterile liquids and solid forms in Yaroslavl (investment 75 million euro). The plant specializes in manufacturing of sterile liquids (in ampoules and vials) and solid forms (in tablets). The plant meets both Russian standards and standards of good manufacturing practice (GMP). The plant produces medicines mostly for the Russian and CIS markets.
JSC R-Pharm is a Russian hi-tech pharmaceutical company. The company is involved in manufacturing of finished dosage forms, innovative pharmaceutical products from a broad number of therapeutic areas in specialty/hospital care, R&D of innovative products and technologies, launch at the Russian market of modern high-efficiency medicines, education and training of specialists for pharmaceutical sphere and health care. R-Pharm operates in Russia and CIS, USA, Germany, Japan, Turkey/MENA and India.
Project in Yaroslavl: JSC R-Pharm Moscow (branch JSC R-Pharm “State-of-the-art Manufacturing Site of Finished Dosage Forms”)
Organization of finished dosage forms production in Yaroslavl (investment 2 920,7 million roubles). R-Pharm’s production of finished dosage forms in Yaroslavl is designed with an account to all latest GMP requirements. Within the project, the company produces drugs for treatment of the most important vital diseases, such as heavy bacterial, virus and fungal infections, oncological diseases, rheumatoid arthritis, hematologic, immunologic diseases, etc.
Teva Pharmaceutical Industries Ltd. is a world-wide leader in production of generics, one of the largest international pharmaceutical companies. Product portfolio of the company includes medicines for cardiology, pulmonology, neurology, psychiatry, endocrinology, gastroenterology, oncology, treatment of osteoporosis and infectious diseases.
Project in Yaroslavl: LLC Teva Moscow (branch LLC Teva Yaroslavl)
Construction of pharmaceutical plant for production of finished dosage forms in Yaroslavl (overall capital investment 2 178,0 million roubles). Construction of the Yaroslavl plant is the first manufacturing facility of the Teva company in Russia. Production plan of the plant includes production release of dry dose medications in form of standard and high-active medications (coated and uncoated pills, dry-filled capsules).
Baltika Breweries LLC, part of the Carlsberg Group, is one of the largest producers and exporters of the Russian beer. The company owns several breweries in Russia and the wide brand portfolio. Apart from the key Baltika brand the company produces such beer brands as Arsenalnoye, Nevskoye, Yarpivo, Tuborg, Carlsberg, Holsten, Kronenbourg 1664, and some non-beer brands. The company has been paying special attention to quality issues: all breweries have installed state-of-the-art equipment, introduced advanced quality management systems; only the best raw materials are used in manufacture of the products.
Projects in Yaroslavl: OJSC Baltika Yaroslavl Brewery
Modernization of manufacturing facilities and logistic system to start new products production (overall capital investment 300 million roubles). The project contributed to quality input, cost reduction, production of premium brands in new packing.
Purchase of new bottling line into PET packing (overall capital investment 400 million roubles). The project provided for bottling of beer in new PET packing of 2,5 litres.
Construction and operation of malting complex (overall capital investment 595,0 million roubles). Malting plant of the Baltika Company in Yaroslavl with a capacity of 110 thousand tons of malt per year is equipped with modern equipment ensuring high manufacturing efficiency, economical operation and environmental friendliness of production. The malt produced in Yaroslavl can be used in production of license brands Carlsberg and Tuborg.
Construction and operation of waste treatment facilities (overall capital investment 407,2 million roubles). Waste treatment facilities of Baltika company is one of the most powerful not only in Russia, but also in Europe. The quality of treated drains corresponds to the requirements set for discharge into fishery waters.
Replacement of steam air heaters of the malting plant for gas heat generators (overall capital investment 108,3 million roubles). New equipment can save around 10% of gas used in malt drying house of the plant. This can substantially decrease environmental burden. Implementation of this technology makes malt production at Baltika Yaroslavl plant one of the most advanced in the industry not only in Russia, but also in Europe.